Mirogabalin as a novel calcium channel α2δ ligand for the treatment of neuropathic pain: a review of clinical update
Neuropathic pain (NP) is often caused by diabetic neuropathy, chemotherapy, or spinal cord lesions and is associated with significant economic burden and poor quality of life. Sophisticated etiology and pathology recognized different pharmacologic interventions, and hitherto, the reported analgesic...
Saved in:
Main Authors: | Fei Yang (Author), Yan Wang (Author), Mingjie Zhang (Author), Shengyuan Yu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mirogabalin-A Novel Selective Ligand for the α2δ Calcium Channel Subunit
by: Renata Zajączkowska, et al.
Published: (2021) -
The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
by: Hui Tang, et al.
Published: (2023) -
Mirogabalin activates the descending noradrenergic system by binding to the α2δ-1 subunit of voltage-gated Ca2+ channels to generate analgesic effects
by: Misa Oyama, et al.
Published: (2021) -
Mirogabalin, a selective gabapentinoid for managing neuropathic pain-A curtain raiser
by: Abhijit Nair
Published: (2022) -
The role of voltage-gated calcium channel α2δ-1 in the occurrence and development in myofascial orofacial pain
by: Yang Lu, et al.
Published: (2024)